ArticleGenes & diseases2026

N6-methyladenosine-modified circLPAR3 drives docetaxel resistance in prostate cancer by suppressing ferroptosis through the PCBP2/CHAC1 axis.

Yetao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.